sysadmin
July 4th, 2004, 12:16
The authors describe a 42-year-old man with insular thyroid carcinoma. In this patient, iodine-131 (I-131) and technetium-99m (Tc-99m) tetrofosmin imaging were performed to investigate residual thyroid tissue and metastatic foci of tumor. Both I-131 and Tc-99m tetrofosmin images showed metastatic foci, but Tc-99m tetrofosmin imaging revealed the lesions better than did the I-131 scan. Tc-99m tetrofosmin imaging does not require withholding of thyroid hormone suppression and can be used for follow-up evaluation of patients with insular thyroid carcinoma.
Clin Nucl Med. 2003 May;28(5):385-8.
Technetium-99m tetrofosmin uptake in insular thyroid carcinoma. A comparison with iodine-131.
Degirmenci B, Aydin A, Comlekci A, Ozdogan O, Bekis R.
Department of Nuclear Medicine, Dokuz Eylul University, School of Medicine, Inciralti, Izmir, Turkey. berna.degirmenci@deu.edu.tr
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12702934
Clin Nucl Med. 2003 May;28(5):385-8.
Technetium-99m tetrofosmin uptake in insular thyroid carcinoma. A comparison with iodine-131.
Degirmenci B, Aydin A, Comlekci A, Ozdogan O, Bekis R.
Department of Nuclear Medicine, Dokuz Eylul University, School of Medicine, Inciralti, Izmir, Turkey. berna.degirmenci@deu.edu.tr
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12702934